BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28552659)

  • 1. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates.
    Rechenchoski DZ; Dambrozio AML; Vivan ACP; Schuroff PA; Burgos TDN; Pelisson M; Perugini MRE; Vespero EC
    Braz J Microbiol; 2017; 48(3):509-514. PubMed ID: 28552659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.
    Lat A; Clock SA; Wu F; Whittier S; Della-Latta P; Fauntleroy K; Jenkins SG; Saiman L; Kubin CJ
    J Clin Microbiol; 2011 May; 49(5):1795-8. PubMed ID: 21367993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.
    Perez LR
    APMIS; 2015 Nov; 123(11):951-4. PubMed ID: 26361367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
    Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
    Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
    Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
    Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
    J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.
    Ribeiro SM; de la Fuente-Núñez C; Baquir B; Faria-Junior C; Franco OL; Hancock RE
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3906-12. PubMed ID: 25896694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M; Ellington MJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
    PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods.
    Bulik CC; Fauntleroy KA; Jenkins SG; Abuali M; LaBombardi VJ; Nicolau DP; Kuti JL
    J Clin Microbiol; 2010 Jul; 48(7):2402-6. PubMed ID: 20484603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.
    Bratu S; Mooty M; Nichani S; Landman D; Gullans C; Pettinato B; Karumudi U; Tolaney P; Quale J
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3018-20. PubMed ID: 15980389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of different methods for susceptibility testing of gentamicin with KPC carbapenemase-producing Klebsiella pneumoniae.
    Arena F; Giani T; Vaggelli G; Terenzi G; Pecile P; Rossolini GM
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):132-4. PubMed ID: 25533616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
    Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
    J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
    Elemam A; Rahimian J; Doymaz M
    J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
    Fattouh R; Tijet N; McGeer A; Poutanen SM; Melano RG; Patel SN
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1556-9. PubMed ID: 26711746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.